Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
letter
. 1993 Apr;35(4):447–448. doi: 10.1111/j.1365-2125.1993.tb04166.x

In vitro interaction between cyclosporin A and macrolide antibiotics.

F Marre, G de Sousa, A M Orloff, R Rahmani
PMCID: PMC1381560  PMID: 8485028

Full text

PDF
447

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Billaud E. M., Guillemain R., Fortineau N., Kitzis M. D., Dreyfus G., Amrein C., Kreft-Jaïs C., Husson J. M., Chrétien P. Interaction between roxithromycin and cyclosporin in heart transplant patients. Clin Pharmacokinet. 1990 Dec;19(6):499–502. doi: 10.2165/00003088-199019060-00006. [DOI] [PubMed] [Google Scholar]
  2. Combalbert J., Fabre I., Fabre G., Dalet I., Derancourt J., Cano J. P., Maurel P. Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily. Drug Metab Dispos. 1989 Mar-Apr;17(2):197–207. [PubMed] [Google Scholar]
  3. Delaforge M., Sartori E., Mansuy D. In vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: comparison with troleandomycin and erythromycin. Chem Biol Interact. 1988;68(3-4):179–188. doi: 10.1016/0009-2797(88)90015-4. [DOI] [PubMed] [Google Scholar]
  4. Fabre G., Bertault-Peres P., Fabre I., Maurel P., Just S., Cano J. P. Metabolism of cyclosporin A. I. Study in freshly isolated rabbit hepatocytes. Drug Metab Dispos. 1987 May-Jun;15(3):384–390. [PubMed] [Google Scholar]
  5. Kohan D. E. Possible interaction between cyclosporine and erythromycin. N Engl J Med. 1986 Feb 13;314(7):448–448. doi: 10.1056/NEJM198602133140715. [DOI] [PubMed] [Google Scholar]
  6. Kreft-Jais C., Billaud E. M., Gaudry C., Bedrossian J. Effect of josamycin on plasma cyclosporine levels. Eur J Clin Pharmacol. 1987;32(3):327–328. doi: 10.1007/BF00607585. [DOI] [PubMed] [Google Scholar]
  7. Lacarelle B., Marre F., Blanc-Gauthier T., Zhou X. J., Placidi M., Catalin J., Rahmani R. Use of human and animal liver microsomes in drug metabolic studies. Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:458–465. [PubMed] [Google Scholar]
  8. Marre F., Fabre G., Lacarelle B., Bourrie M., Catalin J., Berger Y., Rahmani R., Cano J. P. Involvement of the cytochrome P-450IID subfamily in minaprine 4-hydroxylation by human hepatic microsomes. Drug Metab Dispos. 1992 Mar-Apr;20(2):316–321. [PubMed] [Google Scholar]
  9. Pichard L., Fabre I., Fabre G., Domergue J., Saint Aubert B., Mourad G., Maurel P. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab Dispos. 1990 Sep-Oct;18(5):595–606. [PubMed] [Google Scholar]
  10. Ptachcinski R. J., Carpenter B. J., Burckart G. J., Venkataramanan R., Rosenthal J. T. Effect of erythromycin on cyclosporine levels. N Engl J Med. 1985 Nov 28;313(22):1416–1417. doi: 10.1056/nejm198511283132214. [DOI] [PubMed] [Google Scholar]
  11. Vernillet L., Bertault-Peres P., Berland Y., Barradas J., Durand A., Olmer M. Lack of effect of spiramycin on cyclosporin pharmacokinetics. Br J Clin Pharmacol. 1989 Jun;27(6):789–794. doi: 10.1111/j.1365-2125.1989.tb03441.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES